Nefopam hydrochloride
The active substance of Nefopam Holsten is nefopam hydrochloride - a pain-relieving medicine that acts on the central nervous system. This medicine is not related to morphine-like pain-relieving medicines (morphine-containing pain-relieving medicines) or aspirin.
Nefopam Holsten is indicated for the relief of moderate or severe pain, such as:
Treatment only concerns pain relief. It does not cure the underlying cause of the disease.
Before taking the medicine, you should inform your doctor or pharmacist:
You should consult a doctor if you have had or currently have any of the above conditions.
Nefopam Holsten is not recommended for children.
You should tell your doctor or pharmacist about all medicines you are currently taking or have recently taken.
Nefopam is contraindicated if you are taking monoamine oxidase inhibitor medicines, such as selegiline, tranylcypromine, or others (medicines used to treat symptoms of depression, panic attacks, social phobia, Parkinson's disease).
The side effects of Nefopam Holsten may be intensified if you are taking other medicines with a similar effect on the central nervous system.
There are many medicines whose depressant effect on the central nervous system may be additive and lead to impaired alertness. These medicines include morphine derivatives (pain-relieving medicines, cough medicines), barbiturates, benzodiazepines, anxiolytics, sedatives, certain antidepressants, certain antihistamines, certain antihypertensives, and baclofen.
Nefopam may affect some benzodiazepine and opioid tests. These tests may give false-positive results in patients taking Nefopam Holsten.
The severity and frequency of side effects increase if Nefopam Holsten is used simultaneously with other pain-relieving medicines, such as codeine, pentazocine, or dextropropoxyphene.
Not applicable.
There are no data on the use of nefopam in pregnant women.
Nefopam Holsten should not be used during pregnancy, unless the clinical situation of the woman justifies treatment with nefopam.
Nefopam Holsten passes into breast milk. Nefopam Holsten should not be used during breastfeeding.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult your doctor before taking this medicine.
You should not drive or operate machinery if you experience any of the following symptoms:
This medicine should always be taken exactly as advised by your doctor or pharmacist. If you are unsure, you should consult your doctor or pharmacist.
The usual dose is 1 tablet 3 times a day, and the initial dose is 2 tablets. About 6 hours after the first dose, treatment can be continued with 1 tablet 3 times a day.
If the pain does not subside, you should contact your doctor. It may be recommended to increase the dose to 2 tablets 3 times a day. You should never take more than 3 tablets at the same time. Therefore, you should never take more than 3 tablets 3 times a day (= 9 tablets).
Taking the tablets with 3 meals a day will allow for regular dosing of the medicine. This will help you remember to take Nefopam Holsten.
Nefopam Holsten is not recommended for children.
If you take a higher dose of Nefopam Holsten than recommended, you should tell your doctor or pharmacist or contact the emergency department of the nearest hospital. You should remember to take the packaging and any remaining medicine with you.
If your heart rate accelerates significantly after taking too much Nefopam Holsten, hospitalization may be necessary. You should inform your doctor. Your doctor may administer diazepam and supportive measures.
If you miss a dose of Nefopam Holsten, you should take the next dose during the next meal. You should not take a double dose to make up for the missed dose.
You should never stop taking Nefopam Holsten on your own. It is very likely that the pain will return. Stopping treatment should always be discussed with your doctor.
If you have any further questions about the use of this medicine, you should consult your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Side effects that may require immediate medical attention:
Frequency not known(cannot be estimated from the available data):
If you experience any side effects, including those not listed in this leaflet, you should tell your doctor or pharmacist or nurse.
Side effects can be reported directly to the Department for Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309, website: https://smz.ezdrowie.gov.pl.
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the carton and blister pack after EXP.
The expiry date refers to the last day of the month stated.
There are no special precautions for storage.
Do not use this medicine if the packaging or any of the tablets is damaged.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Nefopam Holsten is a white, round, biconvex coated tablet with a diameter of 7.1 mm.
The tablets are packaged in PVC/PE/PVDC/Aluminum blisters. The pack contains 30 tablets.
Holsten Pharma GmbH
Hahnstraße 31-35
60528 Frankfurt am Main
Germany
Email: info@holstenpharma.de
Manufacturer
Laboratories BTT
ZI de Krafft
67150 Erstein
France
or
Holsten Pharma GmbH
Hahnstraße 31-35
60528 Frankfurt am Main
Germany
Estonia: Anefaltic 30 mg õhukese polümeerikattega tabletid
Latvia: Anefaltic 30 mg apvalkotās tabletes
Lithuania: Anefaltic 30 mg plėvele dengtos tabletės
Poland: Nefopam Holsten 30 mg tabletki powlekane
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.